By 2030, Russia plans to build at least 10 new pharmaceutical manufacturing facilities, Russian Minister of Industry and Trade Anton Alikhanov said at a meeting between President Vladimir Putin and members of the government.
“The industrial base of the sector has largely been formed. By 2030, it is planned to build at least 10 additional facilities that will specialize in anticancer drugs, hormonal medicines, radiopharmaceuticals, and other socially significant medicines. At the same time, it is now necessary to focus on the transition from an extensive to an innovative model of industry development—shifting the emphasis toward expanding the range of medicines, creating new products, and increasing the level of localization,” he said.
According to the minister, major projects at several sites—in Moscow, Perm, Nizhny Novgorod, Tomsk, Ufa, and the Ryazan Region—will be implemented over the next three years. Some of these facilities are expected to be launched by the end of 2026 or in early 2027.
As previously reported, the biopharmaceutical company AstraZeneca will launch contract manufacturing of five innovative medicinal products this year at the Skopinpharm plant in the Ryazan Region. GxP News has obtained further details of the project.
Source: GxP-news, January 23, 2026.
